Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Defiance Silver Provides Corporate Update
-
Unaudited financial results of VILVI Group for the 12 months of 2024
-
Pearson and AWS Announce Collaboration to Unlock AI-Powered Personalized Learning for Millions of People Globally
-
Bitget Wallet Mitigates Memecoin Volatility with Trading Rebates on BNB Chain
-
Vantage Markets Recognized as 'Most Trusted Broker' at Smart Vision Summit 2025 in Oman
-
Pearson 2024 Preliminary Results (Unaudited)
-
Mkango Resources Limited Announces Executive Compensation and Issue of Shares
-
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults with Giant Cell Arteritis
-
Olight Debuts at IWA OutdoorClassics 2025
-
AB KN Energies will hold a Webinar regarding unaudited financial results for the twelve months of 2024
-
AB KN Energies unaudited financial information for the twelve months of 2024
-
The Board of Directors of Oma Savings Bank Plc launches a new program period for the share savings plan for all personnel
-
DIGITALIST GROUP’S FINANCIAL STATEMENT RELEASE, 1 JANUARY–31 DECEMBER 2024
-
Enefit Green's unaudited financial results Q4 and 12 months of 2024
-
IDEX Biometrics ASA – Information about the first exercise period for warrants (Warrants A) issued in connection with the Private Placement and Subsequent Offering
-
NB Private Equity Partners Announces Transaction in Own Shares
-
Apranga Group interim information for 12 months of 2024
-
Innofactor Plc Financial Statements Bulletin 2024 (IFRS)
-
Texaf: COMMERCIAL SUCCESS OF THE 3 MAJOR NEW PROJECTS SUPPORTING GROWTH OF RECURRING OPERATING PROFIT (+12% in 2024)
-
Pharming Group to participate in March investor conference
-
Year end report 2024
-
Production report for January 2025
-
Tetragon Financial Group Limited January 2025 Monthly Factsheet
-
Capture Love with vivo V50: "VLOVE Portrait Gallery" Opens in Bangkok
-
Eisai Enters into License Agreement for the Development and Distribution of Fibroblast Growth Factor (FGF) Receptor Selective Tyrosine Kinase Inhibitor Tasurgratinib in Greater China Region (Mainland
-
Borregaard ASA: Shares for employees 2025
-
Paratus Reports Q4 2024 Results
-
Key Information Relating to Return of Capital to be Paid by Paratus
-
WebTech Solutions Expands Global Presence with New Offices in UAE and USA
-
World Rare Disease Day: ABIONYX renews its commitment to treat LCAT Deficiency (Norum's disease) and provides an update on its advances
-
FORVIA: FY 2024 RESULTS
-
Allianz Achieves Record Operating Profit of 16.0 Billion Euros
-
FRO – Fourth Quarter and Full Year 2024 Results
-
Transaction in Own Shares
-
Everest Medicines to Hold Investor Calls with Updates on mRNA Therapeutic Vaccine Programs
-
Bekaert: 2024 Full Year Results
-
Bekaert - Update on the Share Buyback Program and the Liquidity Agreement
-
My Wall Transforms the Creator Economy with Seamless Brand Partnerships and Monetization
-
On-Chain AI Platform Atua AI (TUA) Shapes the Future of Decentralized Intelligence with Advanced AI Solutions
-
Colle AI (COLLE) Elevates Digital Asset Creation with Next-Gen AI Solutions and Advanced Blockchain Connectivity
-
7/2025・Trifork Group AG – Initiation of share buyback program
-
CCA and Responsible Carbon Finance Organizations Launch Buyer's Guide to Cookstove Credits
-
Westlake Epoxy Unveils Cutting-Edge Composite Solutions at JEC World 2025
-
Hytera to Highlight Cutting-Edge Body-Worn Cameras and Evidence Management Solutions at MWC25
-
Molecular Partners Announces Participation at Upcoming Investor Conferences and 2024 Financial Results Conference Call
-
Novaturas earned profit of EUR 2.6 mln. in the last quarter and improved its forecasted annual results
-
AS Tallinna Sadam unaudited financial results for Q4 and 2024
-
Start of Day Message
-
6/2025・Trifork Group AG – 2024 annual report and interim report for the quarter ending 31 December 2024
-
Ackermans & van Haaren grows net profit by 15% in 2024 to 460 million euros.
